166 related articles for article (PubMed ID: 33185527)
1. The effect of 0.5% topical timolol cream on regression of superficial infantile haemangioma in the involuting phase: a prospective, randomized, self-controlled study.
Ying H; Han Y; Chen Z; Yu Z; Chang L; Ma G; Chen Q; Chang S; Qiu Y; Lin X
Eur J Dermatol; 2020 Oct; 30(5):591-595. PubMed ID: 33185527
[TBL] [Abstract][Full Text] [Related]
2. Imiquimod 5% cream versus timolol 0.5% ophthalmic solution for treating superficial proliferating infantile haemangiomas: a retrospective study.
Qiu Y; Ma G; Yang J; Hu X; Chen H; Jin Y; Lin X
Clin Exp Dermatol; 2013 Dec; 38(8):845-50. PubMed ID: 23627540
[TBL] [Abstract][Full Text] [Related]
3. Prospective, open-label, rater-blinded and self-controlled pilot study of the treatment of proliferating superficial infantile hemangiomas with 0.5% topical timolol cream versus 595-nm pulsed dye laser.
Ying H; Zou Y; Yu W; Qiu Y; Ma G; Chang L; Gu Y; Lyu D; Lin X
J Dermatol; 2017 Jun; 44(6):660-665. PubMed ID: 28191657
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of topical timolol treatment of infantile haemangioma: a prospective trial.
Borok J; Gangar P; Admani S; Proudfoot J; Friedlander SF
Br J Dermatol; 2018 Jan; 178(1):e51-e52. PubMed ID: 28771668
[No Abstract] [Full Text] [Related]
5. A self-controlled study of intralesional injection of diprospan combined with topical timolol cream for treatment of thick superficial infantile hemangiomas.
Xu P; Yu Q; Huang H; Zhang W; Li W
Dermatol Ther; 2018 May; 31(3):e12595. PubMed ID: 29708630
[TBL] [Abstract][Full Text] [Related]
6. A prospective self-controlled study of topical timolol 0.5% cream for large superficial infantile hemangiomas.
Qiu Y; Yang J; Chen M; Chang L; Wang T; Ma G; Jin Y; Chen H; Lin X
J Dermatol; 2015 Apr; 42(4):363-6. PubMed ID: 25656976
[TBL] [Abstract][Full Text] [Related]
7. Topical timolol maleate for treatment of infantile haemangiomas: preliminary results of a prospective study.
Semkova K; Kazandjieva J
Clin Exp Dermatol; 2013 Mar; 38(2):143-6. PubMed ID: 22731954
[TBL] [Abstract][Full Text] [Related]
8. The Role of Topical Timolol in the Treatment of Infantile Hemangiomas: A Systematic Review and Meta-analysis.
Khan M; Boyce A; Prieto-Merino D; Svensson Å; Wedgeworth E; Flohr C
Acta Derm Venereol; 2017 Nov; 97(10):1167-1171. PubMed ID: 28421234
[TBL] [Abstract][Full Text] [Related]
9. Oral Propranolol With Topical Timolol Maleate Therapy for Mixed Infantile Hemangiomas in Oral and Maxillofacial Regions.
Li G; Xu DP; Tong S; Xue L; Sun NN; Wang XK
J Craniofac Surg; 2016 Jan; 27(1):56-60. PubMed ID: 26716547
[TBL] [Abstract][Full Text] [Related]
10. Predictors of treatment responses of superficial infantile hemangiomas to topical timolol.
Zheng H; Cai Y; Xu Y; Yu Q; Kang B; Chen C; Gong X; Li W
Dermatol Ther; 2022 Nov; 35(11):e15833. PubMed ID: 36106484
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of ulcerated infantile hemangioma with brimonidine-timolol cream: 2 cases report and review of the literature.
Almebayadh M
J Dermatolog Treat; 2020 Jun; 31(4):433-434. PubMed ID: 30973791
[TBL] [Abstract][Full Text] [Related]
12. Fractional carbon dioxide laser-assisted drug delivery of topical timolol solution for the treatment of deep infantile hemangioma: a pilot study.
Ma G; Wu P; Lin X; Chen H; Hu X; Jin Y; Qiu Y
Pediatr Dermatol; 2014; 31(3):286-91. PubMed ID: 24602019
[TBL] [Abstract][Full Text] [Related]
13. [A clinical study of Timolol Maleate Eye Drops for the treatment of superficial infantile hemangiomas].
Linjun Y; Jiachuan X; Baoli S; Qixing X; Chunfen L
Zhonghua Zheng Xing Wai Ke Za Zhi; 2015 Nov; 31(6):440-5. PubMed ID: 27055324
[TBL] [Abstract][Full Text] [Related]
14. Topical Timolol Maleate Treatment of Infantile Hemangiomas.
Püttgen K; Lucky A; Adams D; Pope E; McCuaig C; Powell J; Feigenbaum D; Savva Y; Baselga E; Holland K; Drolet B; Siegel D; Morel KD; Garzon MC; Mathes E; Lauren C; Nopper A; Horii K; Newell B; Song W; Frieden I;
Pediatrics; 2016 Sep; 138(3):. PubMed ID: 27527799
[TBL] [Abstract][Full Text] [Related]
15. RCT of timolol maleate gel for superficial infantile hemangiomas in 5- to 24-week-olds.
Chan H; McKay C; Adams S; Wargon O
Pediatrics; 2013 Jun; 131(6):e1739-47. PubMed ID: 23650294
[TBL] [Abstract][Full Text] [Related]
16. [Topical timolol in the treatment of periocular superficial infantile hemangiomas: a prospective study].
Ye XX; Jin YB; Lin XX; Ma G; Chen XD; Qiu YJ; Chen H; Hu XJ
Zhonghua Zheng Xing Wai Ke Za Zhi; 2012 May; 28(3):161-4. PubMed ID: 22870699
[TBL] [Abstract][Full Text] [Related]
17. Involution of infantile haemangiomas after imiquimod 5% cream.
Barry RB; Hughes BR; Cook LJ
Clin Exp Dermatol; 2008 Jul; 33(4):446-9. PubMed ID: 18485022
[TBL] [Abstract][Full Text] [Related]
18. Topical propranolol for infantile haemangiomas: a systematic review.
Price A; Rai S; Mcleod RWJ; Birchall JC; Elhassan HA
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2083-2089. PubMed ID: 29569772
[TBL] [Abstract][Full Text] [Related]
19. Allergic contact dermatitis caused by timolol eyedrop application for infantile haemangioma.
Sacchelli L; Vincenzi C; La Placa M; Piraccini BM; Neri I
Contact Dermatitis; 2019 Apr; 80(4):255-256. PubMed ID: 30485454
[No Abstract] [Full Text] [Related]
20. Topical timolol solution versus laser in treatment of infantile hemangioma: a comparative study.
Tawfik AA; Alsharnoubi J
Pediatr Dermatol; 2015; 32(3):369-76. PubMed ID: 25740672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]